Did you hear that Eli Lilly, the company that was caught in a big kerfuffle over Zyprexa (Olanzapine), recently released an antidepressant for dogs? The product, called Reconcile (fluoxetine hydrochloride), is a selective serotonin reuptake inhibitor (SSRI) that is prescribed for dogs that suffer separation anxiety. It is prescribed on a dose-to-weight basis for use in conjunction with behavior modification training to help ease anxiety in dogs that become stressed-out when their owners leave them behind to go to work or for other reasons.
“Lilly research shows that 10.7 million, or up to 17 percent of U.S. dogs(1) suffer from separation anxiety,” said Steve Connell, D.V.M., manager of technical, academic and consumer services for companion animal health at Lilly. “We’re thrilled that our first product for dogs can help restore the human-pet bond, which can be compromised when dogs suffer from separation anxiety.”
Reconcile is a chewable flavored tablet that is proven safe for dogs and puppies 6 months or older.
In field studies of approximately 600 dogs, 73 percent of dogs that were receiving Reconcile showed improvement in separation anxiety-related behavior within eight weeks when compared with dogs receiving behavior modification training alone. Within one week of starting Reconcile(TM) treatment and behavior modification training, 42 percent of dogs showed improvement. During trials, the most common adverse reactions to Reconcile were calm or lethargy, reduced appetite, vomiting, shaking, diarrhea, restlessness, excessive vocalization, aggression and — in infrequent cases — seizures. [story]
Considering that the Chinese tainted pet food intended for American and Canadian pets, I wonder what they think of Americans and their pets now?